These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10441393)

  • 1. Benzodiazepine compounds as inhibitors of the src protein tyrosine kinase: screening of a combinatorial library of 1,4-benzodiazepines.
    Ramdas L; Bunnin BA; Plunkett MJ; Sun G; Ellman J; Gallick G; Budde RJ
    Arch Biochem Biophys; 1999 Aug; 368(2):394-400. PubMed ID: 10441393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based virtual screening of Src kinase inhibitors.
    Lee K; Kim J; Jeong KW; Lee KW; Lee Y; Song JY; Kim MS; Lee GS; Kim Y
    Bioorg Med Chem; 2009 Apr; 17(8):3152-61. PubMed ID: 19321350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human T cell activation by novel Src kinase inhibitors is dependent upon the complexity of the signal delivered to the cell.
    Rapecki S; Allen R
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1325-33. PubMed ID: 12438558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase.
    Ghosh S; Zheng Y; Jun X; Mahajan S; Mao C; Sudbeck EA; Uckun FM
    Clin Cancer Res; 1999 Dec; 5(12):4264-72. PubMed ID: 10632369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.
    Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ
    J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.
    Hamby JM; Connolly CJ; Schroeder MC; Winters RT; Showalter HD; Panek RL; Major TC; Olsewski B; Ryan MJ; Dahring T; Lu GH; Keiser J; Amar A; Shen C; Kraker AJ; Slintak V; Nelson JM; Fry DW; Bradford L; Hallak H; Doherty AM
    J Med Chem; 1997 Jul; 40(15):2296-303. PubMed ID: 9240345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle.
    Banes A; Florian JA; Watts SW
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1179-87. PubMed ID: 10565840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel purine derivatives with potent and selective inhibitory activity against c-Src tyrosine kinase.
    Huang H; Ma J; Shi J; Meng L; Jiang H; Ding J; Liu H
    Bioorg Med Chem; 2010 Jul; 18(13):4615-24. PubMed ID: 20570525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of hydroxamate derivatives as metal-mediated inhibitors of a protein tyrosine kinase.
    Gu X; Wang Y; Kumar A; Ye G; Parang K; Sun G
    J Med Chem; 2006 Dec; 49(25):7532-9. PubMed ID: 17149882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Src kinases by a selective tyrosine kinase inhibitor causes mitotic arrest.
    Moasser MM; Srethapakdi M; Sachar KS; Kraker AJ; Rosen N
    Cancer Res; 1999 Dec; 59(24):6145-52. PubMed ID: 10626805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.
    Golas JM; Arndt K; Etienne C; Lucas J; Nardin D; Gibbons J; Frost P; Ye F; Boschelli DH; Boschelli F
    Cancer Res; 2003 Jan; 63(2):375-81. PubMed ID: 12543790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening.
    Lin LG; Xie H; Li HL; Tong LJ; Tang CP; Ke CQ; Liu QF; Lin LP; Geng MY; Jiang H; Zhao WM; Ding J; Ye Y
    J Med Chem; 2008 Aug; 51(15):4419-29. PubMed ID: 18610999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes.
    Kansra S; Stoll SW; Johnson JL; Elder JT
    Mol Pharmacol; 2005 Apr; 67(4):1145-57. PubMed ID: 15615697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel bone-targeted Src tyrosine kinase inhibitor drug discovery.
    Shakespeare WC; Metcalf CA; Wang Y; Sundaramoorthi R; Keenan T; Weigele M; Bohacek RS; Dalgarno DC; Sawyer TK
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):729-41. PubMed ID: 14579523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of multitargeted tyrosine kinase inhibitors: a novel approach.
    Barchéchath S; Williams C; Saade K; Lauwagie S; Jean-Claude B
    Chem Biol Drug Des; 2009 Apr; 73(4):380-7. PubMed ID: 19291100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening of selective multitarget kinase inhibitors by combinatorial support vector machines.
    Ma XH; Wang R; Tan CY; Jiang YY; Lu T; Rao HB; Li XY; Go ML; Low BC; Chen YZ
    Mol Pharm; 2010 Oct; 7(5):1545-60. PubMed ID: 20712327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of SRC-family tyrosine kinases on Na,K-ATPase activity in lens epithelium.
    Bozulic LD; Dean WL; Delamere NA
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):618-22. PubMed ID: 15671290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors.
    Blencke S; Zech B; Engkvist O; Greff Z; Orfi L; Horváth Z; Kéri G; Ullrich A; Daub H
    Chem Biol; 2004 May; 11(5):691-701. PubMed ID: 15157880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.